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Intracranial Dural Metastasis of Ewing’s
Sarcoma: a Case Report
Although intracranial dural metastasis of Ewing’s sarcoma is a very rare finding,
its imaging characteristics are similar to those of its primary form in the central
nervous system. Thus, this tumor must be considered in the differential diagnosis
of extra-axial dural masses.
wing’s sarcoma is a malignant bone tumor that can occur anywhere in the
body, but it is most commonly observed in the long bones of the arms
and legs, the pelvis and in the chest. The predominant sites of metastasis
include the lung (38%), bone (including the spine; 31%), and the bone marrow (11%)
(1). Metastasis of Ewing’s sarcoma to the central nervous system (CNS) is relatively
rare, and most of the previous reports have demonstrated involvement of the bony
calvarium or brain parenchyma (2). We describe here the imaging findings of dural
metastasis of Ewing’s sarcoma, and these imaging findings have not been previously
reported on in the medical literature.
CASE REPORT
A 21-year-old woman presented in 1996 with right arm pain and weakness. She
underwent total laminectomy at C7-T1 with gross total removal of the intradural
tumor and partial removal of the extradural tumor. The pathologic diagnosis was
Ewing’s sarcoma, and it showed the expression of MIC-2 antigen according to
immunohistochemistry. The patient presented with recurrent right side weakness the
following year and so she underwent resection of the recurrent mass followed by
chemotherapy and radiation treatment. No metastatic lesion was found at the time of
the first or second operation. The patient was healthy until August 2004 when she
complained of headache. No recurrent tumor was found in the spine at that time. In
March 2005, she presented with slowly progressing left side weakness and paresthesia.
MRI was performed at 3.0 T, and this showed a mass in the right cerebellopontine
angle cistern with extension into the ipsilateral Meckel’s cave (Figs. 1A, B). The mass
showed a slightly heterogeneous lobulated contour with similar or slightly higher
signal intensity than the cortex on the T2-weighted images, with heterogeneous
enhancement. Several spots of dark signal-intensity were noted within the mass on
MRI, suggesting the presence of hypervascularity, hemorrhage or calcifications. Edema
was noted in the pons and cerebellum adjacent to the mass. Noncontrast CT showed a
spot of subtle high attenuation within the mass, suggesting the possibility of calcifica-
tion or hemorrhage (Fig. 1C). CT also demonstrated a high-attenuation curvilinear
area near the cerebellum, and this showed low signal intensity on T2-weighted
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DOI:10.3348/kjr.2008.9.1.76imaging and no enhancement (Fig. 1A, B). The ipsilateral
internal auditory canal and petrous bone were free of
tumor on both CT and MRI (Fig. 1A C). Catheter angiog-
raphy showed no blood supply from the meningeal
arteries. Surgical resection was performed via a suboccipi-
tal approach with partial removal of the ipsilateral mastoid.
No petrous bone or adjacent brain parenchyma involve-
ment was found. The surgeon observed focal hemorrhage
within the mass. Complete resection of the mass was done
and this was followed by radiation treatment. The
pathologic diagnosis was a metastatic Ewing’s sarcoma
with a MIC-2 antigen expression (Fig. 1D). The curvilinear
area of high attenuation on CT was determined to be
fibrosis on the pathologic examination. The patient again
presented with headache in January 2006. MRI revealed a
new enhancing lesion abutting the anterior falx cerebri,
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Fig. 1. The T2-weighted (A) and postcontrast T1-weighted images
(B) show a mass in the right cerebellopontine angle cistern with
extension into the ipsilateral Meckel’s cave. The mass shows a
slightly heterogeneous lobulated contour with similar or slightly
higher signal intensity than the cortex on the T2-weighted images,
with heterogeneous enhancement. Edema is noted in the pons and
cerebellum adjacent to the mass. Noncontrast CT shows spots of
subtle high-attenuation within the mass (arrows), suggesting the
possibility of calcification or hemorrhage. Also seen is a high-
attenuation curvilinear area between the mass and the cerebellum
(curved arrow), which was determined to be fibrosis on the
pathologic examination (C). The ipsilateral internal auditory canal
and petrous bone are free of tumor on both the CT and MRI (A-C). 
Cand left fovea ethmoidalis was also noted (Fig. 1E). The
FDG PET scan demonstrated increased metabolism in the
mass, suggesting the recurrence of tumor. Radiation
treatment was performed for the lesion.
DISCUSSION
Ewing’s sarcoma has a propensity to metastasize to the
lung, bone and bone marrow. This tumor can also involve
the CNS with a relatively low incidence (5 of 80 patients,
6.3%) being observed in a previous study (3). There are
two reported principal modes of metastatic spread of
Ewing’s sarcoma to the CNS. The first is direct extension
from the skull, which may be the site of both primary and
secondary Ewing’s sarcoma (4). Shuper et al. have
reported that metastases to the brain directly extended
from the skull in two of seven patients with brain metasta-
sis (3). Alternatively, Ewing’s sarcoma may reach the CNS
via hematogenous spread. In their case series, Shuper et al.
also reported that five of seven patients with metastasis of
Ewing’s sarcoma to the brain had parenchymal lesions that
were separate from the skull and meninges, which
suggested hematogenous spread of tumor. Other studies
investigating CNS involvement of Ewing’s sarcoma have
reported that spread through direct extension from the
skull is more frequent than hematogenous spread (5, 6). 
Metastasis to the dura accounts for 9% of all CNS
metastases (7). Various malignant neoplasms, including
breast cancer, prostate cancer, melanoma, multiple
myeloma, malignant lymphoma and leukemia, can
secondarily involve the dura. However, dural metastasis of
Ewing’s sarcoma has rarely been reported on. Only one
case of dural metastasis of Ewing’s sarcoma has been
described in a report of an autopsy series (8). In that
report, the lesion also involved the skull with diffuse,
massive epidural and subdural plaque-like nodules.
Therefore, the dural nodules might have extended from
the skull, which is a frequent metastatic site for this tumor.
A lack of imaging findings in that case makes it difficult to
determine the origin of the dural lesion. In our patient, no
abnormality in the skull abutting the metastatic tumor was
noted on imaging or during surgery. 
Primary Ewing’s sarcoma of the central nervous system
has rarely been reported on. The imaging characteristics of
this rare tumor in an extra-axial location consist of high
attenuation on CT and low signal intensity on T2-weighted
MRI (4). Hemorrhagic components, dural extension and
contrast enhancement were also reported. All three
reported cases showed bone involvement, indicating that
the origin of this rare tumor was the skull and not the dura
(4). Another radiology report also showed similar imaging
findings, but without skull involvement (9), which is very
similar to the findings of our patient. It is not possible to
say whether the resected tumor was a primary Ewing’s
sarcoma or a secondary tumor because we did not confirm
chromosomal translocation by performing fluorescent in
situ hybridization. However, the subsequent recurrence
might suggest that our patient had a metastatic tumor
because primary Ewing’s sarcoma has been reported to
show a more favorable outcome (10).
Our initial differential diagnosis included more common
tumors such as a meningioma. A schwannoma was also
thought to be a possibility following catheter angiography
due to the lack of blood supply from the meningeal
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Fig. 1. Immunohistochemistry demonstrates the MIC-2 antigen expression (D). Follow-up MRI reveals a new enhancing lesion abutting
the anterior falx cerebri and left fovea ethmoidalis, and this suggests metastasis (E).
DEarteries. Relatively lower signal intensity within the mass
on T2-weighted imaging usually suggests hypercellularity,
as is generally found in meningioma, lymphoma or
leukemia. Ewing’s sarcoma is also in the category of
hypercellular tumors, and this hypercellularity is evident in
both primary and secondary tumors. The lack of bone
involvement supports the possibility of hematogenous
spread of the dural lesion in our patient. In addition,
although it was not confirmed pathologically, a new dural
lesion was detected on follow-up imaging, raising the
possibility that the prior lesion had the same mode of
spread. 
In conclusion, dural metastasis of Ewing’s sarcoma is
very rare and its imaging characteristics are similar to those
of a primary tumor, which mimic the findings of a schwan-
noma or meningioma. Despite its rarity, secondary Ewing’s
sarcoma may be included in the differential diagnosis of
extra-axial dural masses. 
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